Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, United Kingdom
Suprecur 150 micrograms Nasal Spray Solution.
| Pharmaceutical Form |
|---|
|
Nasal Spray Solution. The preparation is a clear solution. |
Suprecur nasal spray contains 150 micrograms buserelin, as buserelin acetate, in one spray dose.
150 micrograms buserelin is equivalent to 157.5 micrograms buserelin acetate.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Buserelin |
Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis. |
| List of Excipients |
|---|
|
The nasal spray also contains citric acid, sodium citrate, sodium chloride and benzalkonium chloride in aqueous solution. |
Cartons containing two bottles and two metered-dose pumps (nebulisers).
Each bottle contains l0g solution.
Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, United Kingdom
PL 45043/0049
Date of first Authorisation: 23 April 2002
Date of latest Renewal: 20 January 2005
| Drug | Countries | |
|---|---|---|
| SUPRECUR | Austria, Estonia, Japan, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
